First Quadrant’s Ionis Pharmaceuticals IONS Stock Holding History

First Quadrant’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,082	Closed	-$94K	–	557
2021 Q1	$94K	Sell	2,082 -208	-9%	-$11.6K	0.01%	423
2020 Q4	$129K	Sell	2,290 -14,970	-87%	-$746K	0.01%	404
2020 Q3	$819K	Sell	17,260 -2,991	-15%	-$166K	0.1%	173
2020 Q2	$1.19M	Buy	20,251 +12,312	+155%	+$685K	0.16%	149
2020 Q1	$375K	Sell	7,939 -1,414	-15%	-$78.8K	0.05%	313
2019 Q4	$565K	Sell	9,353 -28,061	-75%	-$1.67M	0.05%	299
2019 Q3	$2.24M	Sell	37,414 -266	-0.7%	-$17.3K	0.21%	118
2019 Q2	$2.42M	Buy	37,680 +37,589	+41,307%	+$2.66M	0.17%	156
2019 Q1	$7K	Buy	+91	New	+$5.87K	﹤0.01%	695

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

First Quadrant's IONS Position: Q2 2021 in Review

First Quadrant sold out of Ionis Pharmaceuticals (IONS) in Q2 2021, closing a stake of 2,082 shares — an estimated $94K sold.

First Quadrant first reported a position in IONS in Q1 2019 and held it in 9 quarters. The position peaked at $2.42M in Q2 2019. 337 funds tracked by Wall St. Rank hold IONS as of Q2 2021.

First Quadrant reported no remaining Ionis Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
First Quadrant sold 2,082 Ionis Pharmaceuticals shares in Q2 2021, an estimated $94K.
First Quadrant first reported a position in Ionis Pharmaceuticals in Q1 2019 and held it in 9 quarters.
First Quadrant's Ionis Pharmaceuticals position peaked at $2.42M in Q2 2019.
337 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2021.

Based on First Quadrant's 13F filing for Q2 2021, filed 23 Jul 2021.